ArticleBMC medicine2022

AstraZeneca COVID-19 vaccine induces robust broadly cross-reactive antibody responses in Malawian adults previously infected with SARS-CoV-2.

Marah G Chibwana et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.